Koenraad Wiedhaup, Founder and CEO of Leyden Labs, and his team have taken a proactive approach to overcome the challenges of protecting people from known viruses and new viruses. They are developing intranasal sprays containing biological molecules that can temporarily protect against a broad range of viruses. This approach is between a vaccine that often gives long-term protection and a therapeutic necessary once someone is infected.
Koenraad says, "This actually gives people the autonomy to protect themselves and to take the nasal spray. And with that, they protect themselves but also others by not transmitting the virus. And indeed, therefore, the additional benefit is that you don't need a healthcare professional to do that. So, which of course, makes such a rollout also easier in the developed world, in places like the US and Europe. But also in more remote areas, where that might be even more important because of the limited availability of healthcare professionals."
@LeydenLabs #LeydenLabs #PandemicPreparedness #coronaviruses #COVID19 #IntranasalMedicine #antiviral #viruses
LeydenLabs.com
Download the transcript here
Empowered Patient Podcast